IAS 19 paras 70-74, adoption of treatment for attributing service following IFRS IC agenda decision of May 2021

GlaxoSmithKline plc – Annual report – 31 December 2021

Industry: pharmaceuticals

4. New accounting requirements (extract)

Where the retirement benefit to which an employee is entitled is capped at a specified number of consecutive years, the Group previously accounted for these employee benefits from the employment commencement date. Following the IFRS IC agenda decision on Attributing Benefit to Periods of Service in May 2021, the Group has adopted the treatment set out in the IFRS IC agenda decision to account for the employee benefits during the last specified number of years where the employee earn the benefit. The impact of the change was a reduction of expenses of £42 million presented in Cost of sales, Selling, general and administration and Research and development.